NORTH AMERICA LIPOSUCTION SURGERY DEVICES MARKET FORECAST 2025-2032

In essence, according to the American Society of Plastic Surgeons, approximately 1.5 million cosmetic procedures were performed in 2022, with around 325,000 of these being liposuction procedures. The high demand for these procedures highlights the region’s emphasis on plastic surgery equipment and growth within the medical aesthetics market.

In the United States, the demand for cosmetic and aesthetic procedures, including liposuction, continues to drive market expansion. The widespread adoption of advanced technologies, a well-established healthcare infrastructure, and a large number of skilled professionals contribute to the increasing use of liposuction devices. Additionally, the growing preference for minimally invasive procedures and heightened awareness of body contouring techniques further fuel market growth.

In Canada, market growth is promoted by a rising interest in cosmetic procedures, particularly as the population ages and there is an increasing preference for non-invasive treatments. The demand for liposuction devices in Canada is supported by the healthcare system, ensuring access to advanced medical technologies. This fosters the adoption of modern liposuction techniques and drives further market development.

The North America liposuction surgery devices market segmentation includes the market by product type and technology. The technology segment is further differentiated into laser-assisted liposuction (LAL), ultrasound-assisted liposuction (UAL), power-assisted liposuction (PAL), BodyJet or water-assisted liposuction (WAL), J-Plasma, tumescent liposuction, and other technologies.

Tumescent liposuction is a widely used liposuction technique that involves injecting a solution of saline, anesthetic, and epinephrine into the treatment area. This approach minimizes bleeding, swelling, and discomfort, facilitating a minimally invasive procedure and improving patient comfort. Tumescent liposuction is commonly employed in healthcare aesthetics for targeted fat transfer applications and non-surgical body contouring.

Likewise, J-Plasma is an advanced liposuction technology that combines helium gas with radiofrequency energy to precisely target and liquefy fat cells. This unique approach enables the device to remove fat effectively while minimizing damage to surrounding tissues, making it a minimally invasive procedure. J-Plasma also promotes skin tightening, as the energy stimulates collagen production, leading to smoother and more sculpted contours. This technology is gaining traction in the market due to its ability to provide quicker recovery and reduced complications. It offers superior aesthetic results, particularly for patients seeking more refined and natural-looking body sculpting outcomes.

Some of the leading players in the North America liposuction surgery devices market include YOLO Medical Inc, Apyx Medical Corporation, MicroAire Surgical Instruments LLC, Hologic Inc, etc.

YOLO Medical Inc is a medical device company specializing in the development and provision of advanced technologies for a wide range of healthcare applications. The company offers an array of products used in diagnostic imaging, minimally invasive procedures, and treatments, with a strong emphasis on cardiology, orthopedics, and general surgery. YOLO Medical’s devices incorporate advanced technologies such as laser therapy, robotics, and imaging systems, enabling healthcare professionals to deliver precise and efficient care. These products are utilized by medical practitioners in hospitals, clinics, and other healthcare settings around the world. Headquartered in Surrey, British Columbia, Canada, YOLO Medical operates in over 50 countries globally.